Medivir and Boehringer Ingelheim in HIV Deal
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 40 (Table of Contents)
Published: 3 Oct-2003
DOI: 10.3833/pdr.v2003.i40.861 ISSN: 1756-7874
Section: General
Abstract
Medivir and Boehringer Ingelheim entered into licensing agreement for Medivir’s antiviral drug, MIV-310 (alovudine) for treating multi-drug resistant HIV-1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS